Payment Disclosure

At Galen, we recognise that being transparent in our actions is an important factor in building and maintaining confidence and trust with the general public, and in demonstrating the integrity of our interactions and relationships with healthcare professionals (HCPs) and healthcare organisations (HCOs).

Galen is fully committed to adhering to The Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry and the European Federation of Pharmaceutical Industries and Associations (EFPIA) HCP/HCO Disclosure Code.  These Codes require pharmaceutical companies to publicly disclose certain transfers of value made directly or indirectly to HCPs and HCOs located in Europe.

The details of our payments to HCPs and HCOs can be found below.


2012 UK Payment Disclosure


2013 UK Payment Disclosure